MVASI 25 mg/mL concentrate for solution for infusion | medicines.ie

Company: Amgen Ireland Ltd
Active Ingredient: Bevacizumab
Strength: Bevacizumab: 25 mg
Dosage Form: Concentrate for solution for infusion
Legal Category: A - prescription, may not be renewed
Last Updated: 25/09/2026

Licence numbers with strength, ATC code and dosage form
Licence number	Strength	ATC Code	Dosage Form
EU/1/17/1246/001	25 mg	L01FG01	Concentrate for solution for infusion
EU/1/17/1246/002	25 mg	L01FG01	Concentrate for solution for infusion

Licence number: EU/1/17/1246/001
Strength: 25 mg
ATC Code: L01FG01
Dosage Form: Concentrate for solution for infusion

Licence number: EU/1/17/1246/002
Strength: 25 mg
ATC Code: L01FG01
Dosage Form: Concentrate for solution for infusion

Amgen Ireland Ltd

21 Northwood Court, Santry, Dublin D09 TX31, Ireland 216 Cambridge Science Park, Milton Road, Cambridge, Cambridgeshire, CB4 0WA, UK

Website: https://www.amgen.co.uk
Telephone: +441223436441
Email: gbinfoline@amgen.com